ISIS 721744
ISIS721744-CS3
Phase 2 small_molecule active
Quick answer
ISIS 721744 for Hereditary Angioedema is a Phase 2 program (small_molecule) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IONIS PHARMACEUTICALS INC
- Indication
- Hereditary Angioedema
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active